Hydroxyurea for treatment of unresectable and recurrent meningiomas. I. Inhibition of primary human meningioma cells in culture and in meningioma transplants by induction of the apoptotic pathway

Restricted access

✓ Meningiomas, which invade intracranial bone structures and the adjacent connective tissue, are frequently unresectable because of their aggressive and recalcitrant growth behavior. They have a high recurrence rate, and in approximately 10% of these tumors there is an increased risk of malignancy. Significant morbidity and mortality rates associated with recurrent meningiomas demand nonsurgical approaches. To date, adjuvant hormonal treatment has not proven beneficial. The anticancer drug hydroxyurea was therefore tested for its potential use in the treatment of meningiomas.

Early-passaged cell cultures were established from 20 different meningiomas. The addition of 5 × 10−4 and 10−3 M hydroxyurea over a period of 5 to 9 days resulted in a remarkable decrease in cell proliferation and even blocked tumor cell growth when compared with untreated cells. A significant arrest of meningioma cell growth in the S phase of the cell cycle was revealed on DNA flow cytometry.

Electron micrographs of hydroxyurea-treated tumor cells showed ultrastructural features consistent with apoptosis, and light microscopy demonstrated DNA fragmentation by in situ DNA strand break labeling. Short-term treatment of meningioma cell cultures with hydroxyurea for 24 to 48 hours resulted in discrete oligonucleosomal fragments (DNA ladder), another characteristic sign of apoptosis. In addition to the in vitro studies, tissue from five different meningiomas was transplanted into nude mice followed by treatment with 0.5 mg/g body weight hydroxyurea over 15 days. In situ DNA strand break labeling demonstrated DNA fragmentation in distinct regions with different tumor cell densities in all hydroxyurea-treated meningioma transplants.

These data provide evidence that hydroxyurea is a powerful inhibitor of meningioma cell growth, most likely by causing apoptosis in the tumor cells. Thus, hydroxyurea may be a suitable chemotherapeutic agent for the long-term treatment of unresectable or semi- to malignant meningiomas, or for preventing recurrent growth of meningiomas after resection.

Article Information

Contributor Notes

Address reprint requests to: Uwe M. H. Schrell, M.D., Neurochirurgische Klinik der Universität Erlangen-Nürnberg, Schwabachanlage 6, 91054 Erlangen, Germany.
Headings
References
  • 1.

    Adegbite ABKhan MIPaine KWEet al: The recurrence of intracranial meningiomas after surgical treatment. J Neurosurg 58:51561983Adegbite AB Khan MI Paine KWE et al: The recurrence of intracranial meningiomas after surgical treatment. J Neurosurg 58:51–56 1983

    • Search Google Scholar
    • Export Citation
  • 2.

    Ariel IM: Therapeutic effects of hydroxyurea. Experience with 118 patients with inoperable tumors. Cancer 25:7057141970Ariel IM: Therapeutic effects of hydroxyurea. Experience with 118 patients with inoperable tumors. Cancer 25:705–714 1970

    • Search Google Scholar
    • Export Citation
  • 3.

    Baisch HBech HPChristensen IJet al: A comparison of mathematical methods for the analysis of DNA histograms obtained by flow cytometry. Cell Tissue Kinet 15:2352491982Baisch H Bech HP Christensen IJ et al: A comparison of mathematical methods for the analysis of DNA histograms obtained by flow cytometry. Cell Tissue Kinet 15:235–249 1982

    • Search Google Scholar
    • Export Citation
  • 4.

    Barbaro NMGutin PHWilson CBet al: Radiation therapy in the treatment of partially resected meningiomas. Neurosurgery 20:5255281987Barbaro NM Gutin PH Wilson CB et al: Radiation therapy in the treatment of partially resected meningiomas. Neurosurgery 20:525–528 1987

    • Search Google Scholar
    • Export Citation
  • 5.

    Beckloff GLLerner HJFrost Det al: Hydroxyurea (NSC32065) in biologic fluids: dose-concentration relationship. Cancer Chemother Rep 48:57581965Beckloff GL Lerner HJ Frost D et al: Hydroxyurea (NSC32065) in biologic fluids: dose-concentration relationship. Cancer Chemother Rep 48:57–58 1965

    • Search Google Scholar
    • Export Citation
  • 6.

    Black PM: Meningiomas. Neurosurgery 32:6436571993Black PM: Meningiomas. Neurosurgery 32:643–657 1993

  • 7.

    Black PMCarroll RGlowacka Det al: Platelet-derived growth factor expression and stimulation in human meningiomas. J Neurosurg 81:3883931994Black PM Carroll R Glowacka D et al: Platelet-derived growth factor expression and stimulation in human meningiomas. J Neurosurg 81:388–393 1994

    • Search Google Scholar
    • Export Citation
  • 8.

    Blankenstein MABlaauw GLamberts SWet al: Presence of progesterone receptors and absence of oestrogen receptors in human intracranial meningioma cytosols. Eur J Cancer Clin Oncol 19:3653701983Blankenstein MA Blaauw G Lamberts SW et al: Presence of progesterone receptors and absence of oestrogen receptors in human intracranial meningioma cytosols. Eur J Cancer Clin Oncol 19:365–370 1983

    • Search Google Scholar
    • Export Citation
  • 9.

    Bloedow CE: Phase II studies of hydroxyurea (NSC-32065) in adults: miscellaneous tumors. Cancer Chemother Rep 40:39411964Bloedow CE: Phase II studies of hydroxyurea (NSC-32065) in adults: miscellaneous tumors. Cancer Chemother Rep 40:39–41 1964

    • Search Google Scholar
    • Export Citation
  • 10.

    Bolton BHWoods LAKaung DTet al: A simple method of colorimetric analysis for hydroxyurea (NSC-32065). Cancer Chemother Rep 46:151965Bolton BH Woods LA Kaung DT et al: A simple method of colorimetric analysis for hydroxyurea (NSC-32065). Cancer Chemother Rep 46:1–5 1965

    • Search Google Scholar
    • Export Citation
  • 11.

    Boyle-Walsh EHashim IASpeirs Vet al: Interleukin-6 (IL-6) production and cell growth of cultured human meningiomas: interactions with interleukin-1 β (IL-1β) and interleukin-4 (IL-4) in vitro. Neurosci Lett 170:1291321994Boyle-Walsh E Hashim IA Speirs V et al: Interleukin-6 (IL-6) production and cell growth of cultured human meningiomas: interactions with interleukin-1 β (IL-1β) and interleukin-4 (IL-4) in vitro. Neurosci Lett 170:129–132 1994

    • Search Google Scholar
    • Export Citation
  • 12.

    Butler WBKelsey WHGoran N: Effects of serum and insulin on the sensitivity of the human breast cancer cell line MCF-7 to estrogen and antiestrogens. Cancer Res 41:82881981Butler WB Kelsey WH Goran N: Effects of serum and insulin on the sensitivity of the human breast cancer cell line MCF-7 to estrogen and antiestrogens. Cancer Res 41:82–88 1981

    • Search Google Scholar
    • Export Citation
  • 13.

    Carroll RSGlowacka DDashner Ket al: Progesterone receptor expression in meningiomas. Cancer Res 53:131213161993Carroll RS Glowacka D Dashner K et al: Progesterone receptor expression in meningiomas. Cancer Res 53:1312–1316 1993

    • Search Google Scholar
    • Export Citation
  • 14.

    Chan RCThompson GB: Morbidity, mortality, and quality of life following surgery for intracranial meningiomas. A retrospective study in 257 cases. J Neurosurg 60:52601984Chan RC Thompson GB: Morbidity mortality and quality of life following surgery for intracranial meningiomas. A retrospective study in 257 cases. J Neurosurg 60:52–60 1984

    • Search Google Scholar
    • Export Citation
  • 15.

    Creasey WACapizzi RLDeConti RC: Clinical and biochemical studies of high-dose intermittent therapy of solid tumors with hydroxyurea (NSC-32065). Cancer Chemother Rep 54:1911941970Creasey WA Capizzi RL DeConti RC: Clinical and biochemical studies of high-dose intermittent therapy of solid tumors with hydroxyurea (NSC-32065). Cancer Chemother Rep 54:191–194 1970

    • Search Google Scholar
    • Export Citation
  • 16.

    Davidson JDWinter TS: A method of analyzing for hydroxyurea in biological fluids. Cancer Chemother Rep 27:971001963Davidson JD Winter TS: A method of analyzing for hydroxyurea in biological fluids. Cancer Chemother Rep 27:97–100 1963

    • Search Google Scholar
    • Export Citation
  • 17.

    DeMonte FSmith HKAl-Mefty O: Outcome of aggressive removal of cavernous sinus meningiomas. J Neurosurg 81:2452511994DeMonte F Smith HK Al-Mefty O: Outcome of aggressive removal of cavernous sinus meningiomas. J Neurosurg 81:245–251 1994

    • Search Google Scholar
    • Export Citation
  • 18.

    Dolenc V: Direct microscopical repair of intracavernous vascular lesions. J Neurosurg 58:8248311983Dolenc V: Direct microscopical repair of intracavernous vascular lesions. J Neurosurg 58:824–831 1983

    • Search Google Scholar
    • Export Citation
  • 19.

    Elford HL: Effect of hydroxyurea on ribonucleotide reductase. Biochem Biophys Res Commun 33:1291351968Elford HL: Effect of hydroxyurea on ribonucleotide reductase. Biochem Biophys Res Commun 33:129–135 1968

    • Search Google Scholar
    • Export Citation
  • 20.

    Fishbein WNCarbone PPFreireich EJet al: Clinical trials of hydroxyurea in patients with cancer and leukemia. Clin Pharmacol Ther 5:5745801964Fishbein WN Carbone PP Freireich EJ et al: Clinical trials of hydroxyurea in patients with cancer and leukemia. Clin Pharmacol Ther 5:574–580 1964

    • Search Google Scholar
    • Export Citation
  • 21.

    Gavrieli YSherman YBen-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:4935011992Gavrieli Y Sherman Y Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493–501 1992

    • Search Google Scholar
    • Export Citation
  • 22.

    Glauert AM: Fixation Dehydration and Embedding of Biological Specimens. Practical Methods in Electron Microscopy Vol 3 Part 2. Amsterdam: North-Holland1975Glauert AM: Fixation Dehydration and Embedding of Biological Specimens. Practical Methods in Electron Microscopy Vol 3 Part 2. Amsterdam: North-Holland 1975

    • Search Google Scholar
    • Export Citation
  • 23.

    Herken RMerker HJKrowke R: Investigation of the effect of hydroxyurea on cell cycle and the development of necrosis in the embryonic CNS of mice. Teratology 18:1031181978Herken R Merker HJ Krowke R: Investigation of the effect of hydroxyurea on cell cycle and the development of necrosis in the embryonic CNS of mice. Teratology 18:103–118 1978

    • Search Google Scholar
    • Export Citation
  • 24.

    Ito SKarnovsky MJ: Formaldehyde-glutaraldehyde fixatives containing trinitrin compounds. J Cell Biol 39:168a169a1968 (Abstract)Ito S Karnovsky MJ: Formaldehyde-glutaraldehyde fixatives containing trinitrin compounds. J Cell Biol 39:168a–169a 1968 (Abstract)

    • Search Google Scholar
    • Export Citation
  • 25.

    Jääskeläinen J: Seemingly complete removal of histologically benign intracranial meningioma: late recurrence rate and factors predicting recurrence in 657 patients. A multivariate analysis. Surg Neurol 26:4614691986Jääskeläinen J: Seemingly complete removal of histologically benign intracranial meningioma: late recurrence rate and factors predicting recurrence in 657 patients. A multivariate analysis. Surg Neurol 26:461–469 1986

    • Search Google Scholar
    • Export Citation
  • 26.

    Kallio MSankila RHakulinen Tet al: Factors affecting operative and excess long-term mortality in 935 patients with intracranial meningioma. Neurosurgery 31:2121992Kallio M Sankila R Hakulinen T et al: Factors affecting operative and excess long-term mortality in 935 patients with intracranial meningioma. Neurosurgery 31:2–12 1992

    • Search Google Scholar
    • Export Citation
  • 27.

    Katsura SSuzuki JWada T: A statistical study of brain tumors in the neurosurgical clinics in Japan. J Neurosurg 16:5705801959Katsura S Suzuki J Wada T: A statistical study of brain tumors in the neurosurgical clinics in Japan. J Neurosurg 16:570–580 1959

    • Search Google Scholar
    • Export Citation
  • 28.

    Kennedy BJ: Hydroxyurea therapy in chronic myelogenous leukemia. Cancer 29:105210561972Kennedy BJ: Hydroxyurea therapy in chronic myelogenous leukemia. Cancer 29:1052–1056 1972

    • Search Google Scholar
    • Export Citation
  • 29.

    Kennedy BJYarbro JW: Metabolic and therapeutic effects of hydroxyurea in chronic myeloid leukemia. JAMA 195:103810431966Kennedy BJ Yarbro JW: Metabolic and therapeutic effects of hydroxyurea in chronic myeloid leukemia. JAMA 195:1038–1043 1966

    • Search Google Scholar
    • Export Citation
  • 30.

    Kennerdell JSMaroon JCMalton Met al: The management of optic nerve sheath meningiomas. Am J Ophthalmol 106:4504571988Kennerdell JS Maroon JC Malton M et al: The management of optic nerve sheath meningiomas. Am J Ophthalmol 106:450–457 1988

    • Search Google Scholar
    • Export Citation
  • 31.

    Kim JHGelbard ASPerez AG: Action of hydroxyurea on the nucleic acid metabolism and viability of HeLa cells. Cancer Res 27:130113051967Kim JH Gelbard AS Perez AG: Action of hydroxyurea on the nucleic acid metabolism and viability of HeLa cells. Cancer Res 27:1301–1305 1967

    • Search Google Scholar
    • Export Citation
  • 32.

    Knosp EPerneczky AKoos WTet al: Meningiomas of the space of the cavernous sinus. Neurosurgery 38:4344441996Knosp E Perneczky A Koos WT et al: Meningiomas of the space of the cavernous sinus. Neurosurgery 38:434–444 1996

    • Search Google Scholar
    • Export Citation
  • 33.

    Koper JWFoekens JABraakman Ret al: Effects of progesterone on the response to epidermal growth factor and other growth factors in cultured human meningioma cells. Cancer Res 50:260426071990Koper JW Foekens JA Braakman R et al: Effects of progesterone on the response to epidermal growth factor and other growth factors in cultured human meningioma cells. Cancer Res 50:2604–2607 1990

    • Search Google Scholar
    • Export Citation
  • 34.

    Koper JWZwarthoff ECHagemeijer Aet al: Inhibition of the growth of cultured human meningioma cells by recombinant interferon-alpha. Eur J Cancer 27:4164191991Koper JW Zwarthoff EC Hagemeijer A et al: Inhibition of the growth of cultured human meningioma cells by recombinant interferon-alpha. Eur J Cancer 27:416–419 1991

    • Search Google Scholar
    • Export Citation
  • 35.

    Krakoff IHBrown NCReichard P: Inhibition of ribonucleoside diphosphate reductase by hydroxyurea. Cancer Res 28:155915651968Krakoff IH Brown NC Reichard P: Inhibition of ribonucleoside diphosphate reductase by hydroxyurea. Cancer Res 28:1559–1565 1968

    • Search Google Scholar
    • Export Citation
  • 36.

    Krakoff IHSavel HMurphy ML: Phase II studies of hydroxyurea (NSC-32065) in adults: clinical evaluation. Cancer Chemother Rep 40:53551964Krakoff IH Savel H Murphy ML: Phase II studies of hydroxyurea (NSC-32065) in adults: clinical evaluation. Cancer Chemother Rep 40:53–55 1964

    • Search Google Scholar
    • Export Citation
  • 37.

    Kurland LTSchoenberg BSAnnegers JFet al: The incidence of primary intracranial neoplasms in Rochester, Minnesota, 1935–1977. Ann NY Acad Sci 381:6161982Kurland LT Schoenberg BS Annegers JF et al: The incidence of primary intracranial neoplasms in Rochester Minnesota 1935–1977. Ann NY Acad Sci 381:6–16 1982

    • Search Google Scholar
    • Export Citation
  • 38.

    Larson JJvan Loweren HRBalko MGet al: Evidence of meningioma infiltration into cranial nerves: clinical implications for cavernous sinus meningiomas. J Neurosurg 83:5965991995Larson JJ van Loweren HR Balko MG et al: Evidence of meningioma infiltration into cranial nerves: clinical implications for cavernous sinus meningiomas. J Neurosurg 83:596–599 1995

    • Search Google Scholar
    • Export Citation
  • 39.

    Levin VAEdwards MSWara WMet al: 5-Fluorouracil and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) followed by hydroxyurea, misonidazole, and irradiation for brain stem gliomas: a pilot study of the Brain Tumor Research Center and the Children's Cancer Group. Neurosurgery 14:6796811984Levin VA Edwards MS Wara WM et al: 5-Fluorouracil and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) followed by hydroxyurea misonidazole and irradiation for brain stem gliomas: a pilot study of the Brain Tumor Research Center and the Children's Cancer Group. Neurosurgery 14:679–681 1984

    • Search Google Scholar
    • Export Citation
  • 40.

    Levin VARodriguez LAEdwards MSet al: Treatment of medulloblastoma with procarbazine, hydroxyurea, and reduced radiation doses to whole brain and spine. J Neurosurg 68:3833871988Levin VA Rodriguez LA Edwards MS et al: Treatment of medulloblastoma with procarbazine hydroxyurea and reduced radiation doses to whole brain and spine. J Neurosurg 68:383–387 1988

    • Search Google Scholar
    • Export Citation
  • 41.

    Livingstone RBCarter SK: Single Agents in Cancer Chemotherapy. New York: Plenum1970 pp 238256Livingstone RB Carter SK: Single Agents in Cancer Chemotherapy. New York: Plenum 1970 pp 238–256

    • Search Google Scholar
    • Export Citation
  • 42.

    Marks SMWhitewell HLLye RH: Recurrence of meningiomas after operation. Surg Neurol 25:4364401986Marks SM Whitewell HL Lye RH: Recurrence of meningiomas after operation. Surg Neurol 25:436–440 1986

    • Search Google Scholar
    • Export Citation
  • 43.

    Maurer-Schultze BSiebert MBassukas ID: An in vivo study on the synchronizing effect of hydroxyurea. Exp Cell Res 174:2302431988Maurer-Schultze B Siebert M Bassukas ID: An in vivo study on the synchronizing effect of hydroxyurea. Exp Cell Res 174:230–243 1988

    • Search Google Scholar
    • Export Citation
  • 44.

    Maxwell MGalanopoulos THedley-Whyte Tet al: Human meningiomas co-express platelet-derived growth factor (PDGF) and PDGF-receptor genes and their protein products. Int J Cancer 46:16211990Maxwell M Galanopoulos T Hedley-Whyte T et al: Human meningiomas co-express platelet-derived growth factor (PDGF) and PDGF-receptor genes and their protein products. Int J Cancer 46:16–21 1990

    • Search Google Scholar
    • Export Citation
  • 45.

    Mesic JBHanks GEDoggett RL: The value of radiation therapy as an adjuvant to surgery in intracranial meningiomas. Am J Clin Oncol 9:3373401986Mesic JB Hanks GE Doggett RL: The value of radiation therapy as an adjuvant to surgery in intracranial meningiomas. Am J Clin Oncol 9:337–340 1986

    • Search Google Scholar
    • Export Citation
  • 46.

    National Institutes of Health: Surveillance Epidemiology and End Results: Incidence and Mortality Data. Bethesda, MD: National Institutes of Health1981National Institutes of Health: Surveillance Epidemiology and End Results: Incidence and Mortality Data. Bethesda MD: National Institutes of Health 1981

    • Search Google Scholar
    • Export Citation
  • 47.

    Olson JJBeck DWSchlechte JAet al: Effect of the antiprogesterone RU-38486 on meningioma implanted into nude mice. J Neurosurg 66:5845871987Olson JJ Beck DW Schlechte JA et al: Effect of the antiprogesterone RU-38486 on meningioma implanted into nude mice. J Neurosurg 66:584–587 1987

    • Search Google Scholar
    • Export Citation
  • 48.

    Petty AMKun LEMeyer GA: Radiation therapy for incompletely resected meningiomas. J Neurosurg 62:5025071985Petty AM Kun LE Meyer GA: Radiation therapy for incompletely resected meningiomas. J Neurosurg 62:502–507 1985

    • Search Google Scholar
    • Export Citation
  • 49.

    Poisson MMagdelenat HFoncin JFet al: [Estrogen and progestin receptors in meningiomas: a study in 22 cases.] Rev Neurol 136:1932031980 (Fr)Poisson M Magdelenat H Foncin JF et al: [Estrogen and progestin receptors in meningiomas: a study in 22 cases.] Rev Neurol 136:193–203 1980 (Fr)

    • Search Google Scholar
    • Export Citation
  • 50.

    Rajewsky MF: Synchronisation in vivo: kinetics of a malignant cell system following temporary inhibition of DNA synthesis with hydroxyurea. Exp Cell Res 60:2692761970Rajewsky MF: Synchronisation in vivo: kinetics of a malignant cell system following temporary inhibition of DNA synthesis with hydroxyurea. Exp Cell Res 60:269–276 1970

    • Search Google Scholar
    • Export Citation
  • 51.

    Rodriguez LAPrados MFulton Det al: Treatment of recurrent brain stem gliomas and other central nervous system tumors with 5-fluorouracil, CCNU, hydroxyurea, and 6-mercaptopurine. Neurosurgery 22:6916931988Rodriguez LA Prados M Fulton D et al: Treatment of recurrent brain stem gliomas and other central nervous system tumors with 5-fluorouracil CCNU hydroxyurea and 6-mercaptopurine. Neurosurgery 22:691–693 1988

    • Search Google Scholar
    • Export Citation
  • 52.

    Rosner FRubin HParise F: Studies on the absorption, distribution, and excretion of hydroxyurea. Cancer Chemother Rep 55:1671731971Rosner F Rubin H Parise F: Studies on the absorption distribution and excretion of hydroxyurea. Cancer Chemother Rep 55:167–173 1971

    • Search Google Scholar
    • Export Citation
  • 53.

    Schrell UMHAdams EFFahlbusch Ret al: Hormonal dependency of cerebral meningiomas. Part 1: Female sex steroid receptors and their significance as specific markers for adjuvant medical therapy. J Neurosurg 73:7437491990Schrell UMH Adams EF Fahlbusch R et al: Hormonal dependency of cerebral meningiomas. Part 1: Female sex steroid receptors and their significance as specific markers for adjuvant medical therapy. J Neurosurg 73:743–749 1990

    • Search Google Scholar
    • Export Citation
  • 54.

    Schrell UMHFahlbusch RAdams EF: Meningiomas and neurofibromatosis for the oncologist. Curr Opin Oncol 6:2472531994Schrell UMH Fahlbusch R Adams EF: Meningiomas and neurofibromatosis for the oncologist. Curr Opin Oncol 6:247–253 1994

    • Search Google Scholar
    • Export Citation
  • 55.

    Schrell UMHFahlbusch RAdams EFet al: Growth of cultured human cerebral meningioma is inhibited by dopaminergic agents. Presence of high affinity dopamine-D1 receptors. J Clin Endocrinol Metab 71:166916711990Schrell UMH Fahlbusch R Adams EF et al: Growth of cultured human cerebral meningioma is inhibited by dopaminergic agents. Presence of high affinity dopamine-D1 receptors. J Clin Endocrinol Metab 71:1669–1671 1990

    • Search Google Scholar
    • Export Citation
  • 56.

    Schrell UMHGauer SKiesewetter Fet al: Inhibition of proliferation of human cerebral meningioma cells by suramin: effects on cell growth, cell cycle phases, extracellular growth factors and PDGF-BB autocrine growth loop. J Neurosurg 82:6006071995Schrell UMH Gauer S Kiesewetter F et al: Inhibition of proliferation of human cerebral meningioma cells by suramin: effects on cell growth cell cycle phases extracellular growth factors and PDGF-BB autocrine growth loop. J Neurosurg 82:600–607 1995

    • Search Google Scholar
    • Export Citation
  • 57.

    Schrell UMHKoch UMarschalek Ret al: Oncostatin M is a potent inhibitor of meningioma cell growth. Presence of a cytokine family (OSM, LIF, IL-6) and their related receptors (gp130, LIF-R, IL-6-R) in human cerebral meningiomas. Exp Clin Endocrinol Diab 103 (Suppl 1):1701995 (Abstract)Schrell UMH Koch U Marschalek R et al: Oncostatin M is a potent inhibitor of meningioma cell growth. Presence of a cytokine family (OSM LIF IL-6) and their related receptors (gp130 LIF-R IL-6-R) in human cerebral meningiomas. Exp Clin Endocrinol Diab 103 (Suppl 1):170 1995 (Abstract)

    • Search Google Scholar
    • Export Citation
  • 58.

    Schrell UMHNomikos PFahlbusch R: Presence of dopamine D1 receptors and absence of dopamine D2 receptors in human cerebral meningioma tissue. J Neurosurg 77:2882941992Schrell UMH Nomikos P Fahlbusch R: Presence of dopamine D1 receptors and absence of dopamine D2 receptors in human cerebral meningioma tissue. J Neurosurg 77:288–294 1992

    • Search Google Scholar
    • Export Citation
  • 59.

    Simpson D: Recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20:22391957Simpson D: Recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20:22–39 1957

    • Search Google Scholar
    • Export Citation
  • 60.

    Sinclair WK: Hydroxyurea: differential lethal effects on cultured mammalian cells during the cell cycle. Science 150:172917311965Sinclair WK: Hydroxyurea: differential lethal effects on cultured mammalian cells during the cell cycle. Science 150:1729–1731 1965

    • Search Google Scholar
    • Export Citation
  • 61.

    Stearns BLosee KABernstein J: Hydroxyurea. A new type of potential antitumor agent. J Med Chem 6:2011963Stearns B Losee KA Bernstein J: Hydroxyurea. A new type of potential antitumor agent. J Med Chem 6:201 1963

    • Search Google Scholar
    • Export Citation
  • 62.

    Taylor BW JrMarcus RB JrFriedman WAet al: The meningioma controversy: postoperative radiation therapy. Int J Radiat Oncol Biol Phys 15:2993041988Taylor BW Jr Marcus RB Jr Friedman WA et al: The meningioma controversy: postoperative radiation therapy. Int J Radiat Oncol Biol Phys 15:299–304 1988

    • Search Google Scholar
    • Export Citation
  • 63.

    Thompson HJStrange RSchedin PJ: Apoptosis in the genesis and prevention of cancer. Cancer Epidemiol Biomarkers Prevent 1:5976021992Thompson HJ Strange R Schedin PJ: Apoptosis in the genesis and prevention of cancer. Cancer Epidemiol Biomarkers Prevent 1:597–602 1992

    • Search Google Scholar
    • Export Citation
  • 64.

    Thurman WGBloedow CHowe CDet al: A phase I study of hydroxyurea. Cancer Chemother Rep 29:1031071963Thurman WG Bloedow C Howe CD et al: A phase I study of hydroxyurea. Cancer Chemother Rep 29:103–107 1963

    • Search Google Scholar
    • Export Citation
  • 65.

    Turner OACraig WMKernohan JW: Malignant meningiomas: a clinical and pathologic study. Surgery 11:811001942Turner OA Craig WM Kernohan JW: Malignant meningiomas: a clinical and pathologic study. Surgery 11:81–100 1942

    • Search Google Scholar
    • Export Citation
  • 66.

    Waelti ERMarkwalder RMarkwalder TM: Interleukin 6 Produktion in primaeren Zellkulturen von Meningiomzellen. Schweiz Med Wschr 121:15121991 (Abstract)Waelti ER Markwalder R Markwalder TM: Interleukin 6 Produktion in primaeren Zellkulturen von Meningiomzellen. Schweiz Med Wschr 121:1512 1991 (Abstract)

    • Search Google Scholar
    • Export Citation
  • 67.

    Walker AERobins HWeinfeld FD: Epidemiology of brain tumors: the national survey of intracranial neoplasms. Neurology 35:2192261985Walker AE Robins H Weinfeld FD: Epidemiology of brain tumors: the national survey of intracranial neoplasms. Neurology 35:219–226 1985

    • Search Google Scholar
    • Export Citation
  • 68.

    Wang JLNister MHermansson Met al: Expression of PDGF beta-receptors in human meningioma cells. Int J Cancer 46:7727781990Wang JL Nister M Hermansson M et al: Expression of PDGF beta-receptors in human meningioma cells. Int J Cancer 46:772–778 1990

    • Search Google Scholar
    • Export Citation
  • 69.

    Weisman ASRaguet SSKelly PA: Characterisation of the epidermal growth factor receptor in human meningioma. Cancer Res 47:217221761987Weisman AS Raguet SS Kelly PA: Characterisation of the epidermal growth factor receptor in human meningioma. Cancer Res 47:2172–2176 1987

    • Search Google Scholar
    • Export Citation
  • 70.

    Weisman ASVillemure JGKelly PA: Regulation of DNA synthesis and growth of cells derived from primary meningiomas. Cancer Res 46:254525501986Weisman AS Villemure JG Kelly PA: Regulation of DNA synthesis and growth of cells derived from primary meningiomas. Cancer Res 46:2545–2550 1986

    • Search Google Scholar
    • Export Citation
  • 71.

    Wyllie AH: The biology of cell death in tumours. Anticancer Res 5:1311361985Wyllie AH: The biology of cell death in tumours. Anticancer Res 5:131–136 1985

    • Search Google Scholar
    • Export Citation
  • 72.

    Yarbro JWKennedy BJBarnum CP: Hydroxyurea inhibition of DNA synthesis in ascites tumor. Proc Natl Acad Sci USA 53:103310351965Yarbro JW Kennedy BJ Barnum CP: Hydroxyurea inhibition of DNA synthesis in ascites tumor. Proc Natl Acad Sci USA 53:1033–1035 1965

    • Search Google Scholar
    • Export Citation
  • 73.

    Young CWSchochetman GHodas Set al: Inhibition of DNA synthesis by hydroxyurea: structure-activity relationships. Cancer Res 27:5355401967Young CW Schochetman G Hodas S et al: Inhibition of DNA synthesis by hydroxyurea: structure-activity relationships. Cancer Res 27:535–540 1967

    • Search Google Scholar
    • Export Citation
  • 74.

    Zante JSchumann IBarlogie Bet al: New preparation and staining procedure for specific and rapid analysis of DNA distribution in Göhde WSchumann IBüchner T (eds): Pulse Cytometry. Ghent: European Press Medicon1976 pp 97106Zante J Schumann I Barlogie B et al: New preparation and staining procedure for specific and rapid analysis of DNA distribution in Göhde W Schumann I Büchner T (eds): Pulse Cytometry. Ghent: European Press Medicon 1976 pp 97–106

    • Search Google Scholar
    • Export Citation
  • 75.

    Zülch KJ: Tumors of meningeal and related tissues in Zülch KJ (ed): Brain Tumors: Their Biology and Pathologyed 3. Berlin: Springer-Verlag1986 pp 357393Zülch KJ: Tumors of meningeal and related tissues in Zülch KJ (ed): Brain Tumors: Their Biology and Pathology ed 3. Berlin: Springer-Verlag 1986 pp 357–393

    • Search Google Scholar
    • Export Citation
  • 76.

    Zülch KJMennel HD: Malignant meningiomas. Adv Neurosurg 2:3111975Zülch KJ Mennel HD: Malignant meningiomas. Adv Neurosurg 2:3–11 1975

    • Search Google Scholar
    • Export Citation
TrendMD
Cited By
Metrics

Metrics

All Time Past Year Past 30 Days
Abstract Views 211 165 10
Full Text Views 132 23 1
PDF Downloads 68 14 0
EPUB Downloads 0 0 0
PubMed
Google Scholar